Eli Lilly & Co. (NYSE:LLY)

Eli Lilly Logo

How Much New Eli Lilly Product Launches Boosted the Bottom Line

Eli Lilly and Co. (NYSE: LLY) reported its second-quarter earnings Thursday before the markets opened. The company had $0.90 in earnings per share (EPS) on $4.98 billion in revenue. That ...
Read Full Story »
biotech

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More

Stocks were indicated marginally higher on Wednesday ahead of another vote in Greece. The trend that is now almost four years old is that investors just keep buying every dip ...
Read Full Story »
Eli Lilly Logo

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

While it appears at least for the time being that the Greek can once again has been kicked down the road, looking for solid more defensive stocks still makes good ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
Eli Lilly Logo

4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now

With second-quarter earnings right around the corner, many investors are trying to size up what stocks have the potential to trade meaningfully higher the rest of the year. A new ...
Read Full Story »
Pills

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye? In 2014, these companies spent about $4.5 billion in advertising alone, notably ...
Read Full Story »
Prescription drugs

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback. The group’s initial version ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More

Stocks were indicated higher on Thursday. With markets close to all-time highs, the one trend seen for nearly four years now is that investors have bought every single stock market ...
Read Full Story »
buy sell

4 Top New Growth Stock Picks From Jefferies

As we get closer to second quarter earnings, many investors on Wall Street and Main Street are starting to concentrate on having stocks in portfolios that can not only hit ...
Read Full Story »
Eli Lilly Logo

Key Analyst Sees Solid Upside in Eli Lilly

Eli Lilly & Co. (NYSE: LLY) has made a big splash in the market over the past year. A key analyst sees this trend continuing despite some potential near-term headwinds. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Bankrate, Eli Lilly, Embraer, Oracle, Southwest Air and More

Stocks were higher on Thursday morning as investors start to move past Greece and think about a Federal Reserve that still looks somewhat dovish. The one path that keeps emerging ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Arista, Baidu, Chevron, Lexmark, Occidental, Salesforce and More

Stocks were up very marginally on Wednesday ahead of what is expected to be a no-rate-hike day from the Federal Reserve. The Greek issues are becoming less of an issue as ...
Read Full Story »
New Netflix Logo

5 Top Performers for the Past Week

Over the course of the past week, the S&P 500 and the Dow Jones Industrial Average rose have gone up and down, ending about flat on the week compared to ...
Read Full Story »
Prescription drugs

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse sees some solid upside in big pharma in the coming years. After the health care sector has made a strong run, this firm believes that it can continue, ...
Read Full Story »